Hims & Hers Health, Inc. CEO Andrew Dudum sold 158,762 Shares.

Filings Track
18 Jun
Andrew Dudum, CEO of Hims & Hers Health, Inc., executed multiple transactions between June 13 and June 16, 2025. On June 13, he exercised options to acquire 164,368 shares but also sold 90,672 shares on the same day. On June 16, further options were exercised to acquire an additional 125,335 shares, followed by sales totaling 158,762 shares, including those held in trust. These transactions might indicate that the CEO perceives the company's stock price to be nearing a peak, potentially causing market fluctuations, and investors should closely monitor the situation.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10